Journal of Cardiovascular Translational Research

, Volume 7, Issue 8, pp 677–691

Use of mHealth Systems and Tools for Non-Communicable Diseases in Low- and Middle-Income Countries: a Systematic Review

  • David Peiris
  • Devarsetty Praveen
  • Claire Johnson
  • Kishor Mogulluru

DOI: 10.1007/s12265-014-9581-5

Cite this article as:
Peiris, D., Praveen, D., Johnson, C. et al. J. of Cardiovasc. Trans. Res. (2014) 7: 677. doi:10.1007/s12265-014-9581-5


With the rapid adoption of mobile devices, mobile health (mHealth) offers the potential to transform health care delivery, especially in the world’s poorest regions. We systematically reviewed the literature to determine the impact of mHealth interventions on health care quality for non-communicable diseases in low- and middle-income countries and to identify knowledge gaps in this rapidly evolving field. Overall, we found few high-quality studies. Most studies narrowly focused on text messaging systems for patient behavior change, and few studies examined the health systems strengthening aspects of mHealth. There were limited literature reporting clinical effectiveness, costs, and patient acceptability, and none reporting equity and safety issues. Despite the bold promise of mHealth to improve health care, much remains unknown about whether and how this will be fulfilled. Encouragingly, we identified some registered clinical trial protocols of large-scale, multidimensional mHealth interventions, suggesting that the current limited evidence base will expand in coming years.


mHealth Mobile health Non-communicable diseases Low and middle income countries Evidence Quality Evaluation 



Non-communicable diseases


Low- and middle-income countries


Cardiovascular disease


United Nations


World Health Organization Package of Essential NCD interventions


Primary health care


Mobile health


Excerpta Medica database


Cumulative Index to Nursing and Allied Health Literature


Latin American and Caribbean Health Science Literature Database


World Health Organization


Randomized controlled trial

Supplementary material

12265_2014_9581_MOESM1_ESM.pdf (24 kb)
Supplementary Tables S1(PDF 24 kb)
12265_2014_9581_MOESM2_ESM.pdf (16 kb)
Supplementary Tables S2(PDF 15 kb)
12265_2014_9581_MOESM3_ESM.pdf (6 kb)
Supplementary Tables S3(PDF 5 kb)
12265_2014_9581_MOESM4_ESM.pdf (16 kb)
Supplementary Tables S4(PDF 15 kb)
12265_2014_9581_MOESM5_ESM.pdf (8 kb)
Supplementary Tables S5(PDF 8 kb)
12265_2014_9581_MOESM6_ESM.pdf (5 kb)
Supplementary Tables S6(PDF 4 kb)
12265_2014_9581_MOESM7_ESM.pdf (4 kb)
Supplementary Tables S7(PDF 4 kb)
12265_2014_9581_MOESM8_ESM.pdf (44 kb)
Supplementary Tables S8(PDF 43 kb)

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • David Peiris
    • 1
  • Devarsetty Praveen
    • 2
    • 3
  • Claire Johnson
    • 1
  • Kishor Mogulluru
    • 2
  1. 1.George Institute for Global HealthUniversity of SydneySydneyAustralia
  2. 2.George Institute for Global Health - IndiaNew DelhiIndia
  3. 3.Sydney Medical SchoolUniversity of SydneySydneyAustralia

Personalised recommendations